Cite
HARVARD Citation
Yang, X. et al. (2021). Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway. Journal of pharmacy and pharmacology. pp. 263-271. [Online].